tradmap

KVUE Kenvue

$19.34 -1.18%

Data as of close

S&P 500 CompaniesDividend Aristocrats

Held by SPYVOOIVVNOBL

Basic Materials · Perfumes, Cosmetics & Other Toilet Preparations

Kenvue (KVUE) is a basic materials company in the Perfumes, Cosmetics & Other Toilet Preparations industry, with a market capitalization of $37.2 billion. Shares last traded at $19.34, 3.9% below their 52-week high. Over the past year the stock is up 35.1%. KVUE trades at a price-to-earnings ratio of 21.99, below the Perfumes, Cosmetics & Other Toilet Preparations median of 22.89. Net profit margin is 10.9%, above the peer median of 3.4%. Revenue declined 2.1% year over year. The shares yield 5.4% in dividends.

Market Cap
$37.2B
Shares Out
1.92B
EPS (TTM)
$0.87
P/E (TTM)*
21.99
P/S Ratio
2.39
P/B Ratio
3.66
Dividend / Share
$1.04
Dividend Yield
5.39%
52-Week High
$20.12
52-Week Low
$14.02
Volume (venue)
4.0M
Avg Vol (3m, venue)
1.6M

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-1.18%
1M
+12.12%
3M
+1.79%
6M
+10.96%
YTD
+11.95%
1Y
+35.06%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
60.37
SMA (50)
$18.41
SMA (200)
$18.19
Price vs SMA50
+5.06%
Price vs SMA200
+6.30%
ATR (14)
$0.38

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$15.5B
Net Income
$1.7B
Gross Margin
58.3%
Operating Margin
17.4%
Net Margin
10.9%
Return on Equity
16.6%
Return on Assets
6.3%
Current Ratio
0.96
Debt / Equity
0.81
Revenue Growth (YoY)
-2.1%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-27. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

KVUE Dividend History

Dividend / share (TTM)
$1.04
Dividend yield
5.39%
Per-share growth (2y CAGR)
+40.9%
Payout ratio (latest FY)
108%
Fiscal year endTotal dividends paidPer share*Payout ratio
2025-12-28 $1.58B $0.82 108%
2024-12-29 $1.55B $0.81 151%
2023-12-31 $766M $0.41 46%

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

KVUE is a Dividend Aristocrat (25+ consecutive years of increases). Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $0.22 2026-10-30
Q2 2026 $0.24 2026-08-06
Q1 2026 $0.25 2026-05-07
Q4 2025 (derived) $0.16 2026-02-20
FY 2025 $0.76 2026-02-20
Q3 2025 $0.21 2025-11-03

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Perfumes, Cosmetics & Other Toilet Preparations peers

KVUE vs 14 industry peers (Perfumes, Cosmetics & Other Toilet Preparations), by market cap. Data as of close

P/E vs peers
21.99 / 22.89 med
-4% discount
P/S vs peers
2.39 / 2.44 med
-2% discount
Net margin vs peers
10.9% / 3.4% med
above median
1–14 of 14
CLColgate-Palmolive$77.4B37.723.649.6%+2.22%
ELEstée Lauder Companies (The)$38.0B103.132.482.4%-4.11%
KVUEKenvue$37.2B21.992.3910.9%-1.18%
ELFE.L.F. Beauty, Inc.$6.5B109.573.713.4%-0.89%
IPARInterparfums Inc$3.8B22.892.5611.2%+3.03%
COTYCoty Inc.$3.0B—0.52-10.4%+1.62%
EPCEdgewell Personal Care Co$1.3B—0.64-4.5%-0.14%
SLSNSOLESENCE, INC.$60M—1.09-3.4%+0.59%
AXILAxil Brands, Inc.$40M14.301.329.3%+2.82%
UGUNITED GUARDIAN INC$33M13.522.9722.0%+5.68%
CABRCaring Brands, Inc.$10M—2416.79—-14.57%
YCBDcbdMD, Inc.$5M—0.22-13.8%+5.10%
HLNHaleon Plc————+1.21%
ODDOddity Tech Ltd———13.7%-2.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.